ASGE Recognized Industry Associate (ARIA) Training Program for Sanofi | June 2022-Session 11 - Pathophysiology & Current Treatment of EoE

Video Transcription

Video Summary

In this video, the speaker discusses eosinophilic esophagitis (EOE), a disease that causes inflammation in the esophagus. The speaker expresses their gratitude to the ASG for the opportunities provided to them in their personal and professional development. They also emphasize the importance of raising awareness about EOE among non-experts.<br /><br />The speaker addresses misconceptions about the seriousness of EOE, clarifying that while it is not life-threatening, it significantly affects quality of life and can cause anxiety. They highlight the need for education and physician awareness about the disease.<br /><br />The video discusses various treatment options for EOE, including diet, proton pump inhibitors (PPIs), topical corticosteroids, and dilation. The speaker explains the pros and cons of each treatment and emphasizes the importance of assessing response to therapy through endoscopy, histology, and symptom resolution.<br /><br />The speaker also mentions novel developments in EOE treatment, including biologics such as dupilumab, sendakumab, laryntilumab, and atrazumab. They highlight the potential benefits of these treatments for refractory EOE.<br /><br />In conclusion, the speaker summarizes the goals of EOE therapy, the need for shared decision-making, the importance of long-term therapy, and the ongoing research in the field. They express gratitude to the Seeger consortium and patient advocacy groups for their contributions to EOE research.

Keywords

eosinophilic esophagitis

inflammation

treatment options

biologics

refractory EOE

endoscopy

symptom resolution

research